Clinical Trials Logo

Clinical Trial Summary

To explore the efficacy of fecal microbiota transplantation (FMT) in improving the gastrointestinal symptoms and autism symptoms in patients diagnosed as autism spectrum disorder (ASD) comorbid with gastrointestinal symptoms.


Clinical Trial Description

This trial is designed to reconstruct the intestinal micro-ecology of children with ASD by the interventional treatment of FMT. At the same time, combined with metagenomics and 16S rRNA sequencing techniques, the trial aims to study the efficacy of intestinal micro-ecology for the treatment of autism symptoms and the improvement of gastrointestinal problems and autism symptoms in autistic patients, and to explore potential new techniques for treating children with ASD. ;


Study Design


Related Conditions & MeSH terms

  • ASD Accompanied by Moderate to Severe Gastrointestinal Symptoms

NCT number NCT04142255
Study type Interventional
Source Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Contact
Status Terminated
Phase Early Phase 1
Start date November 18, 2019
Completion date June 1, 2020